Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
For quite a while now, the perception of the STEM
The Nobel Prize in Physiology or Medicine awarded
Shilpa Medicare – the full-service contract de
Alembic Pharmaceuticals Limited (Alembic) today an
Since it’s an ingredient in so many foods, you h
Dear Readers, Welcome to the latest issue of Micr
US medical experts will be meeting on Friday to debate and vote on the controversial question of giving out booster doses of Pfizer’s COVID-19 vaccine to the general population.
President Joe Biden’s administration announced in August a plan to roll out third shots to everyone, not just the immune compromised already able to receive them, starting from September 20. However, the experts have since expressed reservations about whether they are required, amid concerns over global inequity, the greater need to vaccinate the unvaccinated, and possible increased risk of side effects.
If the FDA panel votes yes, it will fall to another committee convened by the Centres for Disease Control and Prevention (CDC) on September 22-23 to decide who should receive the booster first and when they should get it. The CDC has previously indicated it sees the elderly, nursing home residents and health care workers as likely first in line.
Moderna is suggesting the usage of a Covid booster shot — which the World Health Organization (WHO) has protested.
“It is promising to see clinical and real-world evidence adding to the growing body of data on the effectiveness of the Moderna COVID-19 vaccine,” Moderna CEO Stéphane Bancel said insisting on the need of a booster shot.
